Kalorama Information market research studies have the data you need on the drug discovery market opportunity, providing analysis, projections, and information on market direction. Drug discovery operations can prove time-consuming and difficult, and may come at a high economic cost, which has driven outsourcing in this field. Kalorama explores an important segment, the contract research organization segment, looking in detail at an approach that is helping to shape the drug discovery market today.
- Display 15 Products per page
In Vitro Toxicology Market
Published: July 19, 2018 | Price: $4,500.00 – $9,000.00
In Vitro Toxicology In Vitro Toxicology analyses global in vitro toxicity testing markets and various market segments with the objective to identify the important market trends that will bring further growth in this market. The study aims to derive crucial insights that will benefit all the major stakeholders of the industry in developing strategic business plans based on these emerging trends. The report provides market size and growth trends for various toxicity endpoint segments for 2018-2023, including ADME-Tox; cytotoxicity; genotoxicity;...
100 Companies in Contract Pharmaceutical Research – White Paper
Published: March 27, 2018 | Price: $0.00
This brief White Paper lists over one hundred companies that are involved in drug discovery in one form or another. A company website and address is provided for each company. The White Paper does not detail companies or discuss the CRO marketplace - for this purpose, please consult our recent report, Outsourcing in Drug Discovery, 8th Edition.
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition
Published: March 20, 2018 | Price: $4,500.00 – $9,000.00
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition In eight editions, Kalorama Information's report, Outsourcing in Drug Discovery, has kept the industry informed, providing answers to these questions and more. The 8th edition contains 2017 market size estimates and 2022 forecasts for 21 different parts of the process that might be outsourced, including: Chemistry Services Market, 2017-2022 Building Blocks Outsourcing Market, 2017-2022 Compound Synthesis Market, 2017-2022 Library Construction Market, 2017-2022 Process Research Market, 2017-2022 Biology Services...
Outsourcing in Drug Discovery, 7th Edition
Published: April 26, 2016 | Price: $3,360.00 – $6,720.00
Outsourcing in Drug Discovery, 7th Edition This Kalorama Information study, Outsourcing in Drug Discovery, provides details estimates and forecasts of the contract research organization market and an in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for chemistry, biology and lead optimization. The report also provides an overview of the CRO drug discovery process, and...
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, Forecasts to 2018, 6th Edition
Published: April 30, 2014 | Price: $995.00 – $1,990.00
For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process. This Kalorama Information Report, Outsourcing in Drug Discovery, t provides an in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for the following segments. Chemistry Services Market: Building Blocks, Compound Synthesis, Libraries,...
The World Market for Pain Management Drugs and Devices
Published: May 20, 2013 | Price: $1,500.00 – $2,250.00
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and as a result, the range of therapeutic options available to physicians and other clinicians has expanded. Solutions to pain disorders are still elusive but continued human and animal studies will help to further identify the biochemical and neurophysiological factors that influence pain. The future of pain...
The Next Wave In Cancer Treatment – Kinase Inhibitors
Published: December 4, 2012 | Price: $500.00 – $1,000.00
This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. Several cancers are being treated with these newer therapies, which provide a focus of cancer profiled in this report, including: Breast Colorectal Head/Neck Kidney Leukemia Liver Lung Melanoma Ovarian Pancreatic Prostate Stomach The report covers both currently marketed and late stage development kinase inhibitors for cancer treatment. Revenues for this market segment were generated using dollar...
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
Published: May 11, 2012 | Price: $3,995.00 – $7,990.00
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the original leads. There are several steps in the drug discovery...
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition
Published: June 1, 2010 | Price: $3,995.00 – $7,990.00
Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 22 suppliers, representative of those active in this market. Segments covered in this report include: Chemistry Services Building Blocks Compound Synthesis Libraries Process Research Other Services Biology Services Protein...
Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals), The
Published: October 1, 2009 | Price: $3,500.00 – $7,000.00
The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to them. This Kalorama Information The World Market for Anti-Infectives considers the anti-infective drug market as it faces challenges with resistance and generic competition. The report focuses on three key segments of...
Clinical Nutrition Products: World Markets, 3rd Edition
Published: February 1, 2009 | Price: $3,995.00 – $7,590.00
This Kalorama Information report - Clinical Nutrition - focuses on three primary segments of essential medical nutrition: Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort) Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients) Parenteral Nutrition For each category, the report provides revenue data and forecasts for the most important segmentations. The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates, over 65 population, and overall...
Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
Published: January 1, 2009 | Price: $995.00 – $7,000.00
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. A major factor driving the upward trend in the number of manufacturing projects being outsourced is that specialized production, i.e., sterile manufacturing, biopharmaceutical manufacturing and specialized processes, such as chiral chemistry and improvements in catalyst activity, is often not included in the...
Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
Published: October 1, 2008 | Price: $3,500.00 – $7,000.00
Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. Kalorama Information's Outsourcing in Drug Development is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues. Part of the CMO Market Series,...
World Alzheimer’s Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends), The
Published: August 1, 2008 | Price: $1,500.00 – $4,995.00
Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments. There is an opportunity for pharmaceutical companies to compete in this market, as Kalorama analyst Melissa Elder outlines in this study. This report includes incidence of Alzheimer’s disease worldwide with information...
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Published: May 1, 2008 | Price: $3,500.00 – $7,000.00
2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent protection for many drug product. And there is also pressure to reduce the time spent in drug discovery and to bring drugs to market sooner, as well as the ever-present cost considerations....